Acadia Pharmaceuticals (ACAD) Raw Materials (2016 - 2026)
Acadia Pharmaceuticals' Raw Materials came in at $67.16 million for Q2 2026, down 19.7% from $83.68 million a year earlier and down 9.7% from the prior quarter.
Powered by 
Analysis
Acadia Pharmaceuticals (ACAD) Raw Materials (2016 - 2026) Analysis & Trends
At the end of FY2025, Acadia Pharmaceuticals' Raw Materials was $82.78 million, up 18.7% from FY2024.
- Raw Materials has increased in each of the last three years, with a five-year compound annual growth rate of 113.6% (FY2020 to FY2025).
- Going back by year, Raw Materials was $69.74 million in FY2024 (+122.7%), $31.31 million in FY2023 (+501.3%), $5.21 million in FY2022 (-16.2%) and $6.22 million in FY2021 (+233.9%).
- The Q2 2026 figure represents the lowest quarterly Raw Materials since Q3 2024.
- Year-over-year, Raw Materials increased in six of the last eight quarters, with growth averaging 54.7%.
- The fastest year-over-year change in Raw Materials over five years came in Q1 2024 (growth of 934.4%), and the weakest in Q2 2026 (a decline of 19.7%).
- Business Quant data shows ACAD's Raw Materials at $74.33 million (Q1 2026), $82.78 million (Q4 2025) and $77.78 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn |
| 10 | Acadia Pharmaceuticals | 2.95 Bn | -526.50 Mn | 279.64 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 67.16 Mn |
| Mar 31, 2026 | 74.33 Mn |
| Dec 31, 2025 | 82.78 Mn |
| Sep 30, 2025 | 77.78 Mn |
| Jun 30, 2025 | 83.68 Mn |
| Mar 31, 2025 | 76.50 Mn |
| Dec 31, 2024 | 69.74 Mn |
| Sep 30, 2024 | 42.18 Mn |
| Jun 30, 2024 | 63.50 Mn |
| Mar 31, 2024 | 53.52 Mn |
| Dec 31, 2023 | 31.31 Mn |
| Sep 30, 2023 | 16.26 Mn |
| Jun 30, 2023 | 6.81 Mn |
| Mar 31, 2023 | 5.17 Mn |
| Dec 31, 2022 | 5.21 Mn |
| Sep 30, 2022 | 5.99 Mn |
| Jun 30, 2022 | 6.21 Mn |
| Mar 31, 2022 | 6.21 Mn |
| Dec 31, 2021 | 6.22 Mn |
| Sep 30, 2021 | 6.22 Mn |
API Access
Acadia Pharmaceuticals Raw Materials API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=raw-materials&ticker=ACAD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "raw-materials", "ticker": "ACAD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=raw-materials&ticker=ACAD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();